Altre lingue Protara Therapeutics, Inc.

Azioni

TARA

US74365U1079

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 10/05/2024			Variaz. 5gg	Var. 1 gen.
3 ^USD	+0,67%		+3,81%	+59,99%

02/05	Protara Therapeutics, Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
05/04	Protara Therapeutics, Inc. annuncia l'allineamento con la FDA sul percorso registrativo per il cloruro di colina per via endovenosa nei pazienti che dipendono dalla nutrizione parenterale	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Protara Therapeutics: Q1 Earnings Snapshot	02/05
Protara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business Update	02/05
Protara Therapeutics, Inc. announced that it has received $44.998327 million in funding from a group of investors	30/04
Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing	05/04
Protara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition	05/04
Protara Therapeutics, Inc Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition	05/04
Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC	05/04
Protara Therapeutics, Inc. Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC	05/04
Protara Therapeutics, Inc. Announces Resignation of Jathin Bandari as Chief Medical Officer, Effective April 11, 2024	18/03
Protara Therapeutics: Q4 Earnings Snapshot	13/03
Protara Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
Protara Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	13/03
Protara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	13/03
Proteon Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
North American Morning Briefing : Stock Futures -2-	13/03
Top Premarket Gainers	12/03
Protara Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference	28/02
Top Premarket Decliners	12/02
Protara Therapeutics to Participate in Upcoming Investor Conferences	31/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Protara Therapeutics, Inc.

Azioni

TARA

US74365U1079

Altre lingue

Filtri